Misinterpreted annual report: No, Biontech does not question the effectiveness and safety of its vaccine

published

A screenshot is circulating on social media that allegedly proves that there are considerable doubts about the Corona vaccine from Biontech/Pfizer. But the conclusions drawn are wrong.

von

Fee Anabelle Riebeling

1 / 9

We may not be able to demonstrate sufficient efficacy or safety of our Covid-19 vaccine to receive permanent approval in the US, UK, EU or other countries where it is approved for emergency use or has received conditional market approval.» – This phrase caused a stir on social media.

Screenshot Twitter

Some people take it as Biontech admitting that its Covid-19 vaccine is not doing what is promised.

Some people take it as Biontech admitting that its Covid-19 vaccine is not doing what is promised.

Screenshot Facebook

Some relevant portals also interpret the statement in this way.  But they misinterpret the whole thing.

Some relevant portals also interpret the statement in this way. But they misinterpret the whole thing.

Screenshot Twitter.

  • According to some social media posts and reports, the company Biontech doubts the safety and effectiveness of its own mRNA preparation.

  • As evidence, supporters of this claim cite a passage from a recent release by the company to the US Securities and Exchange Commission.

  • But the passage has been taken out of context and misinterpreted.

  • The quoted paragraph is a warning required by the stock exchange regulator to avoid possible claims for damages by investors.

As of April 10, 2022, the companies Biontech and Pfizer have shipped “more than 3.3 billion doses worldwide” of the joint Covid-19 vaccine. This is what the US group tells 20 minutes. Billions of doses have already been vaccinated. Like Moderna’s vaccine, also an mRNA vaccine, Comirnaty is considered safe and highly effective.

But now a screenshot is circulating on social media that allegedly proves that the developer himself is not at all convinced of his vaccine: “It is possible that we are not able to ensure that our Covid 19 vaccine is sufficiently effective or safe to obtain permanent approval in the US, UK, EU or other countries where it is approved for emergency use or has received conditional marketing approval. The corresponding point is highlighted in yellow (see photo gallery) and is mockingly commented on, among other things, on Twitter and Facebook. But wrongly.

Risk naming serves as a safeguard

The highlighted statement has been taken out of context. The screenshot shows only a small excerpt of a report that is actually several hundred pages long and is addressed to the US Securities and Exchange Commission. Specifically, this is a so-called 20-F form (Form 20-F, see box), which was published on March 30, 2022 on the Biontech website.

All foreign securities issuers that have listed stocks on US stock exchanges are required to file a 20-F document with the US Securities and Exchange Commission annually. The purpose of the Form 20-F is to unify the reporting requirements of foreign-based companies so that investors can value these investments alongside domestic stocks. The structure and procedure are fixed accordingly. For example, a Form 20-F must be filed within four months of the company’s fiscal year-end. In addition, cautionary statements must be included with regard to forward-looking statements by management. According to the Nerdwire.de portal, these should avoid possible claims for damages from investors.

In accordance with the Form 20-F requirements, all conceivable risks for the business result are also mentioned in the Biontech report. Even if there is no reason for this. Their mention serves only as a safeguard and is therefore legally motivated, according to Nerdwire.de. “The imponderables listed in the paper (from page 4) also include the competition from other vaccines and their efficiency, costs, transport and storage options, safety, side effects and durability of the immune response.”

Biontech stands behind its Corona vaccine

The Biontech publication is not an admission of guilt, as claimed by social media users and relevant portals such as Epochtimes.de, Tkp.at and the Report24.news site, which is known for spreading false reports . Also, unlike the Bavarian AfD politician Andreas Winhard in a media release, the company is not “subdued”. The authors also ignore in their interpretation of the report that the Biontech/Pfizer vaccine received full approval in the US in August 2021. It applies to everyone over the age of 16.

Rather, Biontech confirms the current state of science: the in-house vaccine “offers a high level of protection against questionable variants, including alpha, beta and delta”. It goes on to say on page 91 of the report that laboratory studies have shown that three doses of BNT162b2, as Comirnaty is also known, neutralize the Sars-CoV-2 omicron variant.

In connection with the novel corona virus and the pandemic, new rumors and theories have repeatedly emerged in recent months. 20 minutes took care of many of them. You can find the Corona fact check ticker here.

Are you or is someone you know struggling with the Corona period?

Subscribe to the knowledge channel notifications in the 20-minute app. You will be informed about groundbreaking findings and discoveries from research, explanations of current events and curious news from the wide world of science. You will also receive answers to everyday questions and tips for a better life.

This is how it works: Install the latest version of the 20-minute app. Tap on “Cockpit” in the bottom right, then “Settings” and finally on “Push notifications”. Under “Topics” you tap on “Knowledge” – et voilà!

As a member, you become part of the 20-minute community and benefit from great benefits and exclusive competitions every day!

As a member, you become part of the 20-minute community and benefit from great benefits and exclusive competitions every day!

Share:

Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

On Key

Related Posts